HomeATRA • NASDAQ
add
Atara Biotherapeutics Inc
Previous close
$7.40
Day range
$7.26 - $7.68
Year range
$4.97 - $45.75
Market cap
43.38M USD
Avg Volume
176.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 28.64M | 2,892.69% |
Operating expense | 8.91M | -33.17% |
Net income | -19.05M | 73.21% |
Net profit margin | -66.51 | 99.10% |
Earnings per share | -3.10 | 81.76% |
EBITDA | -16.54M | 76.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 35.29M | -77.03% |
Total assets | 117.28M | -52.41% |
Total liabilities | 228.15M | -4.53% |
Total equity | -110.87M | — |
Shares outstanding | 4.92M | — |
Price to book | -0.33 | — |
Return on assets | -31.63% | — |
Return on capital | 89.16% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -19.05M | 73.21% |
Cash from operations | -10.64M | 79.84% |
Cash from investing | 7.20M | -85.46% |
Cash from financing | -324.00K | -168.79% |
Net change in cash | -3.77M | -32.71% |
Free cash flow | -3.64M | 85.91% |
About
Founded
2012
Headquarters
Website
Employees
165